| Value | ₹1,358 Cr |
|---|
NSE filing, NSE: MANORAMA. Summary written from the filing by ALFA Finder's alert engine.
Manorama Industries Ltd: key numbers
- Share price
- ₹1,796.20
- Market cap
- ₹11,338 Cr
- Revenue (annual)
- ₹1,367 Cr
- Net profit (annual)
- ₹224.9 Cr
- P/E (TTM)
- 46.0×Sector 22.8×
- Promoter holding
- 51.38%-2.94% QoQ
- FII holding
- 4.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manorama Industries Ltd
All →Manorama Industries Annual General Meeting
Manorama Industries Limited announced the voting results of its postal ballot, confirming the appointment of Dr. Rohini Tiwari as a Non-Executive Independent Director.
Manorama Industries Other Announcement
Manorama Industries submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming dematerialization activities processed by its RTA.
Manorama Industries Capital Structure Change
Manorama Industries' board approved up to Rs.30 Crore in capital infusions across three wholly-owned subsidiaries. The funds target working capital and general corporate purposes in Benin, Togo and Ivory Coast.
- Value
- ₹30.00 Cr
Manorama Industries Annual General Meeting
Manorama Industries issued a postal ballot notice to appoint Dr. Rohini Tiwari as Non-Executive Independent Director. E-voting window runs September 19 to October 18, 2026.
Manorama Industries Management Change
Manorama Industries Limited has appointed Dr. Rohini Tiwari as a Non-Executive Independent Director, while Mudit Kumar Singh concluded his tenure on the board.
Manorama Industries Board Meeting Outcome
Manorama Industries approved the appointment of an additional director, postal ballot processes, and a combined ₹75 Crore capital infusion into six of its wholly owned subsidiaries.
- Value
- ₹75.00 Cr
Other results update announcements
All →Medi Assist Healthcare Services Results Update
Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.
Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.
Surani Steel Tubes Results Update
Surani Steel Tubes issued an earnings press release for H1 FY27, reporting revenue of Rs.290.86 Crore and PAT of Rs.5.94 Crore. The release states that both figures exceed the company's previous full-year records.
Shree Ganesh Remedies Results Update
Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.
Zen Technologies Results Update
Zen Technologies released its Q2 and H1 FY27 unaudited results, reporting consolidated Q2 revenue of ₹345.13 Crore, up 98.8% year-on-year. Order book stands at ₹1,375.70 Crore.
- Order book
- ₹1,376 Cr
Sai Parenterals Results Update
Sai Parenterals reported Q2FY27 consolidated revenue of Rs. 196 crore and PAT of Rs. 11 crore. Gross margin improved to 47.5%.